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a b s t r a c t
The aim of the study was to evaluate the effects of a highly potent bisphosphonate,
zoledronic acid (ZOL), on cultured odontoblast-like cells MDPC-23. The cells
(1.5  104 cells/cm2) were seeded for 48 h in wells of 24-well dished. Then, the plain culture
medium (DMEM) was replaced by fresh medium without fetal bovine serum. After 24 h, ZOL
(1 or 5 mM) was added to the medium and maintained in contact with the cells for 24 h. After
this period, the succinic dehydrogenase (SDH) enzyme production (cell viability – MTT
assay), total protein (TP) production, alkaline phosphatase (ALP) activity, and gene expres-
sion (qPCR) of collagen type I (Col-I) and ALP were evaluated. Cell morphology was assessed
by SEM. Five mM ZOL caused a significant decrease in SDH production. Both ZOL concentra-
tions caused a dose-dependent significant decrease in TP production and ALP activity. ZOL
also produced discret morphological alterations in the MDPC-23 cells. Regarding gene
expression, 1 mM ZOL caused a significant increase in Col-I expression. Although 5 mM
ZOL did not affect Col-I expression, it caused a significant alteration in ALP expression
(ANOVA and Tukey’s test, p < 0.05). ZOL presented a dose-dependent cytotoxic effect on the
odontoblast-like cells, suggesting that under clinical conditions the release of this drug from
dentin could cause damage to the pulpo-dentin complex.
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Bisphosphonates are a class of synthetic analogs of pyrophos-
phate, which have been widely used in treatment of diseases
with intense bone activity resorption, such as osteoporosis,
Paget’s disease and some bone tumours, such as multiple
myeloma, and bone metastases of breast and prostate
tumours.1,2
These drugs are physiological modulators of bone resorp-
tion and calcification with high affinity for hydroxyapatite
crystals, thus remaining adhered to the mineralized tissues of
body.3,4 In the same way as the bone tissue, dentin is
characterized as a partially mineralized connective tissue
with great hydroxyapatite content, and recent studies have
been suggested that bisphosphonates can also adhere to this* Corresponding author at: Departamento de Fisiologia and Patologia,
Paulista, Rua Humaita´, 1680. Centro, Caixa Postal: 331, Cep: 14801903 A
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Open access under the Elsevier OA license.dental tissue. However, to date, little is known about how
bisphosphonates adhere to the dental tissues, the mecha-
nisms by which this adherence occurs or the conditions under
which these drugs are released to the pulp.
In vivo studies have demonstrated that treatment with
bisphosphonates during the formation of teeth was associated
with the occurrence of amelogenesis imperfecta and forma-
tion of a disorganized dentin tissue.6,7 Sakai et al.6 reported
that bisphosphonates can adhere to dentin, promoting a
complete or intermittent inhibition of dentinogenesis.
It has been described that bisphosphonates can be released
from mineralized tissues during bone resorption or remodel-
ling.8 It is known that remodelling processes of mineralized
tissues do not occur in the adult dentition. However,
pulpal injuries caused by events, such as trauma and
chronic inflammatory processes, could activate odontoclast Faculdade de Odontologia de Araraquara, Universidade Estadual
raraquara, SP, Brazil. Tel.: +55 16 3301 6477; fax: +55 16 3301 6488.
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ultimately causing the release of these drugs to interact with
the pulp tissue.5 Another hypothesis of the action of bispho-
sphonates on the pulp tissue would be their cytotoxicity at the
moment of infusion. However, it is suggested that, the limited
drug concentration at the moment of infusion would not be
sufficient to produce a cytotoxic effects to the pulp cells.5
Recent studies have shown that bisphosphonates are
cytotoxic to different cell types.5,9–11 Therefore, the release
of this drug to the pulp tissue could promote cytotoxic effects
to the pulp cells, reducing the reparative capacity of this
tissue. In mammalian teeth, odontoblasts are organized in a
monolayer that underlies the coronal and root dentin, and
thus these peripheral pulp cells would be the first to get in
contact with bisphosphonates released from dentin.12,13
Therefore, the aim of this study was to evaluate the effects
of zoledronic acid (ZOL), a highly potent, heterocyclic nitro-
gen-containing bisphosphonate, on odontoblast-like MDPC-23
cells by evaluating succinic dehydrogenase (SDH) enzyme
production (cell viability – MTT assay), total protein (TP)
production, alkaline phosphatase (ALP) activity, reverse
transcriptase polymerase chain reaction (qPCR) for collagen
type I (Col-I) and ALP, and morphology (scanning electron
microscopy – SEM).
2. Material and methods
2.1. MDPC-23 cell culture
The odontoblast-like cells MDPC-23 used in this study were
cultivated in Dulbecco’s Modified Eagle’s Medium (DMEM;
Sigma Aldrich Corp., St. Louis, MO, USA) supplemented with
10% fetal bovine serum (FBS; Gibco, Grand Island, NY, USA)
and containing 100 IU/mL penicillin, 100 mg/mL streptomycin
and 2 mmol/L glutamine (Gibco) in an humidified incubator
with 5% CO2 and 95% air at 37 8C (Isotemp Fisher Scientific,
Pittsburgh, PA, USA). The MDPC-23 cells in DMEM containing
10% FBS were sub-cultured at every 2 days until an adequate
number of cells were obtained for the study, and then plated
(1.5  104 cells/cm2) onto sterile 24-well plates (Costar Corp.,
Cambridge, MA, USA), which were maintained in the
humidified incubator with 5% CO2 and 95% air at 37 8C for
48 h. Three groups were then established: one control group,
which received no treatment, and two experimental groups,
which were treated with ZOL at concentrations of 1 mM and
5 mM.
2.2. ZOL on MDPC-23 cell culture
Zoledronic acid (ZOL) was selected for investigation in the
present study because it is a high potent bisphosphonate and,
according to recent studies,14,15 is one of the most frequently
prescribed bisphosphonates. In addition, several workers
reported that this nitrogen containing bisphosphonate may
cause intense cytotoxic effects in different types of cell
cultures, including pulp cells.10,11,16
After the 48-incubation period, the culture medium was
aspirated and replaced by fresh FBS-free DMEM containing
ZOL (Zometa 4 mg; Novartis Biocieˆncias S.A., Sa˜o Paulo, SP,Brazil) at concentrations of either 1 mM or 5 mM, according to
the group. These concentrations were chosen based on a study
by Scheper et al.17 who showed that ZOL can be found at these
concentrations in the alveolar bone and saliva of patients
under treatment with this drug. The culture medium with the
drug remained in contact with the cells in the incubator with
5% CO2 and 95% air at 37 8C for 24 h.
2.3. Analysis of cell viability (SDH production – MTT
assay)
Cell viability was evaluated using the methyltetrazolium
(MTT) assay.18–20 This method determines the activity of
SDH enzyme, which is a measure of cellular (mitochondrial)
respiration, and can be considered as the metabolic rate of
cells. After 24 h of incubation of the cells in contact with DMEM
alone (control group) or containing the two ZOL concentra-
tions (experimental groups), the culture medium was aspirat-
ed and replaced by 900 mL of fresh DMEM plus 100 mL of MTT
solution (5 mg/mL sterile PBS). The cells were incubated at
37 8C for 4 h. Thereafter, the culture medium with the MTT
solution was aspirated and replaced by 700 mL of acidified
isopropanol solution (0.04 N HCl) in each well to dissolve the
violet formazan crystals resulting from the cleavage of the
MTT salt ring by the SDH enzyme present in the mitochondria
of viable cells, producing a homogenous bluish solution. After
agitation and confirmation of the homogeneity of the
solutions, three 100 mL aliquots of each well were transferred
to a 96-well plate (Costar Corp.). Cell viability was evaluated by
spectrophotometry as being proportional to the absorbance
measured at 570 nm wavelength with an ELISA plate reader
(Thermo Plate, Nanshan District, Shenzhen, Gandong, China).
The values obtained from the three aliquots were averaged to
provide a single value. The absorbance was expressed in
numerical values, which were subjected to statistical analysis
to determine the effect of ZOL on the mitochondrial activity of
the cells.
2.4. Total protein expression
Total protein expression was evaluated as previously de-
scribed.20 After 24 h of incubation of the cells in contact with
DMEM alone (control group) or containing the two ZOL
concentrations (experimental groups), the culture medium
with ZOL was aspirated and the cells were washed three times
with 1 mL PBS at 37 8C. An amount of 1 mL of 0.1% sodium
lauryl sulphate (Sigma Aldrich Corp., St. Louis, MO, USA) were
added to each well and maintained for 40 min at room
temperature to produce cell lysis. The samples were homoge-
nized and 1 mL from each well was transferred to properly
labelled Falcon tubes (Corning Incorporated, Corning, NY,
USA). One millilitre of distilled water was added to the blank
tube. Next, 1 mL of Lowry reagent solution (Sigma Aldrich
Corp.) was added to all tubes, which were agitated for 10 s in a
tube agitator (Phoenix AP 56, Araraquara, SP, Brazil). After
20 min at room temperature, 500 mL of Folin-Ciocalteau’s
phenol reagent solution (Sigma Aldrich Corp.) were added to
each tube followed by 10 s agitation. Thirty min later, three
100 mL aliquots of each tube were transferred to a 96-well plate
and the absorbance of the test and blank tubes was measured
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Plate). Total protein production was calculated from a
standard curve created using known protein concentrations.
2.5. ALP activity
Analysis of ALP activity was performed using the colorimet-
ric endpoint assay (ALP Kit; Labtest Diagno´stico S.A., Lagoa
Santa, MG, Brazil) employed in previous studies.20 This test
uses a thymolphthalein monophosphate substrate, which is
a phosphoric acid ester substrate. ALP hydrolyzes the
thymolphthalein monophosphate substrate, releasing thy-
molphthalein. Therefore, it is possible to measure directly
the product of hydrolysis, altering the pH. The altered pH
interrupts the enzymatic activity and provides bluish colour
to the solution, which is characteristic of the reaction. The
intensity of the resulting colour is directly proportional to
the enzymatic activity and is analyzed spectrophotometri-
cally. After 24 h incubation of the cells in contact with
DMEM alone (control group) or containing the two ZOL
concentrations (experimental groups), the culture medium
with ZOL was aspirated and the cells were washed three
times with 1 mL PBS at 37 8C. An amount of 1 mL of 0.1%
sodium lauryl sulphate (Sigma Aldrich Corp.) were added to
each well and maintained for 40 min at room temperature to
produce cell lysis. The test was performed according to the
instructions of the Kit’s manufacturer. The absorbance of
the samples was measured at 590 nm wavelength with a
spectrophotometer (Thermo Plate). ALP activity was calcu-
lated by a standard curve using known concentrations of the
enzyme.
2.6. Analysis of cell morphology by SEM
SEM analysis was used to identify possible morphological
alterations caused by the addition of different concentra-
tions of ZOL to DMEM culture medium in which the MDPC-23
cells were cultured. The following protocol used in previous
studies was employed.20,21 Sterile 13-mm-diameter cover
glasses (Fisher Scientific, Pittsburgh, PA, USA) were sterilized
in 70% ethanol for 24 h and placed on the bottom of the wells
immediately before seeding the cells. After 24 h of incuba-
tion of the cells in contact with DMEM alone (control group)
or containing the two ZOL concentrations (experimental
groups), the culture medium with ZOL was aspirated and the
cells were fixed in 1 mL of 2.5% glutaraldehyde in PBS for 1 h.
Then, the glutaraldehyde was removed and the cells were
washed with PBS and post-fixed with 1% osmium tetroxide
for 1 h at room temperature. The cells that remained
adhered to the glass substrate were washed with PBS and
distilled water two consecutive times (5 min each) and then
dehydrated in a series of increasing ethanol concentrations
(30, 50 and 70%, one time for 30 min each; 95 and 100%, two
times for 60 min each) and covered three times with 200 mL
of 1,1,1,3,3,3-hexamethyldisilazane (HMDS; Sigma Aldrich
Corp.) at 20 min intervals. The cells were mounted on
metallic stubs, stored in a desiccator overnight, sputter-
coated with gold, and their morphology was examined with
a scanning electron microscope (JMS-T33A scanning micro-
scope, JEOL, Tokyo, Japan).2.7. Analysis of Col-I and ALP expression
2.7.1. RNA extraction and cDNA synthesis
The effects of ZOL on Col-I and ALP expression was evaluated
after 48 h of contact of the drug with the cells by two-step real
time polymerase chain reaction (qPCR), which is a sensitive
and fast method to evaluate gene expression. Unlike conven-
tional PCR, this technique needs a small number of samples,
less methodological standardization and no contaminant
reagents. Another advantage is that the amplification can
be observed at any cycle, and no post processing of samples is
required.22
For this test, the cell were transferred to microcentrifuge
tubes to which 1 mL of trizol (Invitrogen, Carlsbad, CA, USA)
was added to inhibit the action of RNAases and the cells were
incubated for 5 min at room temperature. Next, 0.2 mL of
chloroform was added for each 1.0 mL de trizol (Sigma Aldrich
Corp., St. Louis, MO, USA) to promote release of the
cytoplasmic proteins. The tubes were agitated manually for
15 s, left rest for 2–3 min at room temperature, and centrifuged
at 1200 rcf (Microcentrifuge Eppendorf model 5415R, Eppen-
dorf, Hamburg, Germany) for 15 min at 4 8C. After centrifuga-
tion, the samples presented three phases: a precipitated
phase, corresponding to the organic portion (phenol, chloro-
form, DNA), an intermediate phase (proteins) and a more
aqueous supernatant phase, corresponding to RNA (RNA and
buffer).
The aqueous phase was aliquoted to a new tube, in which
0.5 mL of isopropanol (Sigma–Aldrich Corp.) was added for
each 1.0 mL of trizol to promote precipitation of RNA in
solution. The samples were maintained at room temperature
for 10 min and then centrifuged at 12,000 rcf for 10 min at 4 8C.
After this stage, formation of a precipitated fraction (pellet)
was observed at the bottom of the tube. The supernatant
fraction was discarded and the precipitated phase was dried
by inverting the tubes onto a blotting paper sheet during
10 min. After drying, 1.0 mL of 75% ethanol (Sigma–Aldrich
Corp.) was added for each 1.0 mL of trizol and the samples
were agitated and centrifuged at 7500 rcf for 5 min at 4 8C. The
supernatant fraction was discarded and the RNA was
subjected to the same drying procedure for 30 min. Next,
the RNA was resuspended in 10 mL of ultrapure water
(Invitrogen) and the resulting solution was incubated at
55 8C for 10 min. Part of the obtained RNA (1.0 mL) was diluted
in ultrapure water at 1:50 for quantification of RNA in an
Eppendorf biophotometer (model Eppendorf RS-232C, Eppen-
dorf, Hamburg, Germany).
cDNA was synthesized from each RNA sample for qPCR
using the High Capacity cDNA Reverse Transcriptions Kit
(Applied Biosystems, Foster City, CA, USA), according to the
following protocol. In a microcentrifuge tube were added 10
RT Buffer, 10 RT Random Primers, 25 dNTP Mix, reverse
transcriptase and 0.5 mg of the RNA of each sample. The
samples were then subjected to the following amplification
cycling conditions: 25 8C (10 min), 37 8C (120 min), 85 8C (5 s)
and 4 8C thereafter.
2.7.2. qPCR
After cDNA synthesis, the expression of the genes that encode
for Col-I and ALP was evaluated by qPCR. For each gene,
Table 1 – Primer sequences used for analysis of gene
expression of the odontoblast-like cells MDPC-23 (Mus
musculus) subjected to treatment with zoledronic acid.
Gene Sequences of primers
Col-I Forward – 50 ACG TCC TGG TGA
AGT TGG TC 30
Reverse – 50 CAG GGA AGC CTC
TTT CTC CT 30
ALP Forward – 50 GCT GAT CAT TCC
CAC GTT TT 30
Reverse – 50 CTG GGC CTG GTA
GTT GTT GT 30
b-actin Forward – 50 AGC CAT GTA CGT
AGC CAT CC 30
Reverse – 50 CT CTC AGC TGT GGT
GGT GAA 30
Table 2 – Data from SDH production, TP production and
ALP activity of MDPC-23 cells exposed to zoledronic acid
(ZOL) at different concentrations.
Group SDH
productiona
TP
productionb
ALP
activityb
Control group 0.659 (0.094)a 284.47 (27.81)a 155.99 (45.11)a
1 mM ZOL 0.567 (0.204)ab 190.05 (17.73)b 86.60 (39.59)b
5 mM ZOL 0.450 (0.117)b 171.86 (30.03)b 87.02 (40.01)b
All values are given as mean (standard deviation), n = 8.
a Values expressed in absorbance (470 nm).
b Values expressed in U/L. Means followed by same letters in
columns do not differ significantly (Tukey’s test, p > 0.05).
Fig. 1 – Col-I and ALP expression (qPCR) of MDPC-23 cells
exposed to zoledronic acid (ZOL) at different
concentrations. Columns represent means and error bars
represent standard deviations, n = 4. Columns indicated
with the same letters do not differ significantly (Tukey’s
test, p > 0.05).
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(Table 1). The reactions were prepared with standard reagents
for qPCR (Syber Green PCR Master Mix; Applied Biosystems)
together with the primer/probe sets specific for each gene
(Table 1). The fluorescence readings were performed using the
Step One Plus System (Applied Biosystems) at each amplifica-
tion cycle, and were analyzed subsequently using the Step One
Software 2.1 (Applied Biosystems). All reactions were sub-
jected to the same analytical conditions and were normalized
by the ROXTM passive reference dye signal to correct
fluctuations on reading resulting from variations of volume
and evaporation during the reaction. The result, expressed in
CT values, refers to the number of cycles necessary for the
fluorescent signal to reach the detection threshold. The
individual results expressed in CT values were recorded in
worksheets, grouped according to the groups and normalized
according to the expression of the selected endogenous
reference gene (b-actin). Then, the RNAm concentrations of
each target gene were analyzed statistically.
2.8. Statistical analysis
After analysis of data distribution (Shapiro-Wilk, p > 0.05) and
homogeneity of variances (Levene, p > 0.05), cell viability (SDH
production), TP production, ALP activity and Col-I and ALP
expression data were independently subjected to one-way
analysis of variance (treatment: control, 1 mM or 5 mM ZOL). Once
rejected the null hypothesis of absence of differences among the
groups, additional Tukey’s tests were also applied for pairwise
comparison. A significance level of 5% was set for all analyses.
3. Results
Data from SDH production, TP production and ALP activity are
presented in Table 2. The use of 1 mM ZOL did not cause a
significant ( p > 0.05) reduction in SDH production compared
with the control group. However, SDH production decreased
significantly compared with the control group ( p < 0.05) when
ZOL concentration increased to 5 mM. No statistically signifi-
cant difference was found between the 1 and 5 mM ZOL
concentrations (Table 2).Application of ZOL on the odontoblast-like cells caused a
significant ( p < 0.05) decrease in TP production and ALP
activity (Table 2) compared with the control group. No
statistically significant difference ( p > 0.05) was found be-
tween the 1 and 5 mM ZOL concentrations (Table 2).
Col-I and ALP expression detected by qPCR are presented in
Fig. 1. When the MDPC-23 cells were exposed to ZOL at 5 mM
concentration, Col-I expression did not differ significantly
( p > 0.05) from the control group in which the drug was not
used. On the other hand, exposure to 1 mM ZOL stimulated the
odontoblast-like cells to produce Col-I, leading to a statistically
significant increase ( p < 0.05) in its expression compared to
the other groups. A statistically significant decrease ( p < 0.05)
in ALP expression was observed when the cells were exposed
to 5 mM ZOL compared with the expression of this protein in
the other groups (control and 1 mM ZOL).
The SEM analysis of the odontoblast-like cells MDPC-23
incubated in contact with ZOL revealed that both concentra-
tions of the drug induced morphological alterations, especially
reduction of cell size, which created large intercellular spaces
and exposed the cover glass that served as substrate for cell
culture. On the other hand, in the control group, the MDPC-23
cells were near confluence and had a wide cytoplasm covering
the entire surface of the glass substrate (Fig. 2).
Fig. 2 – SEM micrographs showing the morphology of odontoblast-like cells MDPC-23 not treated (control group) and
exposed to zoledronic acid at 1 mM or 5 mM. In the control group, cells are near confluence covering the entire surface of the
glass substrate. In the experimental groups, the cells exhibited shrunken cytoplasm and loss of their normal morphology.
In addition, it can be noted that cells detached from the glass substrate, leaving cell-free spaces. SEM, Original
magnification 500T.
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Bisphosphonates have been indicated for treatment of
osteopenic and osteoporotic conditions.2 The high affinity of
bisphosphonates for Ca2+ ions and their strong binding to
hydroxyapatite promotes a rapid incorporation of these drugs
to the tissues.4 ZOL is a highly potent nitrogen-containing
bisphosphonate that presents a prolonged adhesion to bone
surface and effect, and has been widely used for various
clinical conditions.14
A recent study5 demonstrated that bisphosphonates may
adhere to dentin because this mineralized dental tissue is very
similar to those of bone tissue. This adhesion process may
occur during odontogenesis, in children treated with these
drugs during the formation and mineralization of dental
tissues, as well as during physiological deposition of second-
ary dentin.15
Events that induce bone resorption or remodelling are
capable of triggering the osteoclastic activity, resulting in
adherence of the osteoclasts to the bone surfaces and decrease
of local pH. The consequent loss of affinity between bispho-
sphonates and the mineralized tissue leads to drug release
from the tissue.23
Regarding the oral cavity, some factors, such as progression
of caries lesions, dental trauma and toxicity of dental
materials may disorganize the odontoblast layer or even the
pre-dentin, triggering and activating the action of local clasts,
which starts the dentin resorption process.13,24,25 The induc-
tion of these events in patients under bisphosphonate therapy
may result in release of the drug adhered to dentin
hydroxyapatite, intensifying the damages to the dentinopul-
par complex. When bisphosphonates are released from
dentin, the pulp odontoblasts are the first cell line exposed
to these drugs because they underlies the dentin and are
responsible for its formation and maintenance.12,13
A previous study26 using dentin discs showed that bispho-
sphonates are capable to adhere to dentin, inhibiting its
resorption. Other studies revealed that daily administration of
bisphosphonates during periods of 7 and 14 days affected the
mineralization of the dentin matrix6 and that the infusion of
some types of bisphosphonates in rats caused enamel anddentin malformations.7 More recently, the findings of a
bioassay showed that the ZOL concentrations found in the
oral cavity of patients under treatment with this drug ranged
from 0.4 to 5 mM.17 Thereafter, some authors have demon-
strated that this drug can be toxic to different cell types, such
as osteoblasts, endothelial cells and fibroblasts.10,11,16 This
cytotoxic effect could be due to contact of high concentrations
of bisphosphonates released from the mineralized tissues to
the adjacent cells. A recent study5 evaluating the cytotoxicity
of ZOL to pulp cells in vitro showed that this drug caused a
significant decrease of the viability, proliferation and TP
production of these cells. These data were confirmed in the
present study in which ZOL concentrations (1 mM and 5 mM)
simulating those found in the alveolar bone tissue of patients
under treatment with this drug,17 caused reduction of cell
viability.
In addition to the analysis of odontoblast-like cell viability,
TP production and ALP activity, molecular biology experi-
ments were also carried out in the present study, which
indicated that Col-I and ALP expression can be inhibited in a
dose-dependent by the action of ZOL. This inhibitory effect of
ZOL could affect negatively the repair of the pulpo-dentin
complex in vivo, as Col-I is the main component of reactionary
dentin matrix, which is produced by odontoblasts that suffer
aggressions12,27 and ALP is directly involved in the minerali-
zation of this newly formed dentin matrix.28,29
The present study demonstrated that ZOL at concentration
of 1 mM increase Col-I expression. Similar result was also
reported in previous studies that revealed an increase in the
expression of this gene in vitro within the first days after
contact of the drug with the cells.30,31 However, Col-I
expression decreased over time, suggesting that the inhibitory
effect of ZOL was both dose- and time-dependent.31
The results of ZOL cytotoxicity to the odontoblast-like
MDPC-23 cells demonstrated by the in vitro cellular and
molecular biology protocols used in the present study were
confirmed in the analysis of cell morphology by SEM. The cells
incubated in contact with both ZOL concentrations presented
size reduction, probably due to cytoskeletal shrinkage. This
cell response pattern in contact with low toxic agents has been
extensively described in the literature,19,21 which helps
establishing the effects of the tested drug. This is because
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be due to a direct inhibitory effect of the drug on cell activity,
which results in reversible morphological alterations, or to
necrotic or apoptotic cell death, which represents an irrevers-
ible condition. In both situations, the MTT assay provides
values that represent a smaller number of formazan crystals
formed. However, SEM analysis of the morphology and
number of cells that remained adhered to the glass substrate
provides complementary data that indicate the actual effect of
the drug. This way, the maintenance of the number of MDPC-
23 cells and the discrete alterations in their morphology
observed in present study demonstrate that in spite of
presenting cytotoxic effects, ZOL did not cause direct cell
death even at the higher concentration (5 mM). Perhaps, the
same ZOL concentrations evaluated in the present study (1
and 5 mM) could cause more intense cytopathic effects, if
maintained for a longer time in contact with the odontoblast-
like cell cultures, as described by Koch et al.31
The effects of bisphosphonates on odontoblas-like cells
could be related to the activation of different pathways, such
as Mitogen-activated protein kinase (MAPK), Jun N- terminal
kinase (JNK) as well as caspase pathways that regulate
mitogenic activity, gene expression and apoptosis of cells.17,32
Further in vitro and in vivo studies are necessary to
characterize the relationship between cytotoxicity and the
concentration and contact time of ZOL with blast cells.
5. Conclusions
Based on the methodology used in the present in vitro study
and the obtained results, it may be concluded that ZOL at
concentrations of 1 mM and 5 mM presented a dose-dependent
cytotoxic effects to the odontoblast-like cells MDPC-23 and
decreased the expression of typical dentin matrix proteins,
suggesting that under clinical conditions the release of this
drug from dentin may cause damage to the pulp–dentin
complex.
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